RecruitingNot Applicable

PEGASUS - Improving Treatment for Patients With Emotionally Unstable Personality Disorder

Denmark100 participantsStarted 2024-09-01

Plain-language summary

The purpose of the PEGASUS study is to conduct a pilot trial to test the feasibility and acceptability of the PEGASUS intervention, adding a case manager and family-based interventions meetings to the existing psychiatric integrated care-models known as "Treatment Packages" in Denmark. We will conduct a randomized, assessor-blinded parallel-groups superiority clinical trial, testing the PEGASUS intervention for emotionally unstable personality disorder "EUPD", borderline type (borderline personality disorder) compared to "Treatment as Usual" before moving on to testing in a full-scale trial. Participants will be assessed at baseline and 9 month post baseline at study conclusion

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Participating Patients Inclusion Criteria: * Must be able to give an informed written consent. * Must be newly accepted in the pre-planned BPD treatment packages. * ≥18 years of age. * Agreeing to involvement of one or two informal caregivers, families, or close friends ("Relatives"). * Capable of reading and understanding Danish. Exclusion Criteria: * None\* * Note that to get accepted into a treatment package for BPD, patients must not fulfill the criteria for a F20 diagnosis or the criteria for alcohol or substance abuse or harmful use. Participating Relatives: Inclusion Criteria: * Must be able to give an informed written consent. * ≥18 years of age. * Capable of reading and understanding Danish. Exclusion criteria: None

What they're measuring

Level of functioning

Timeframe: Study inclusion and at 9 months at study completion

Trial details

NCT IDNCT06563466

SponsorUniversity Hospital Bispebjerg and Frederiksberg

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-10-31

Contact for this trial

Ditte H. Rotvig, MD

+45 31154887 ditte.hoeyer.rotvig@regionh.dk